Literature DB >> 19406938

Targeted disruption of carcinoembryonic antigen-related cell adhesion molecule 1 promotes diet-induced hepatic steatosis and insulin resistance.

Elaine Xu1, Marie-Julie Dubois, Nelly Leung, Alexandre Charbonneau, Claire Turbide, Rita Kohen Avramoglu, Luisa DeMarte, Mounib Elchebly, Thomas Streichert, Emile Lévy, Nicole Beauchemin, André Marette.   

Abstract

Carcinoembryonic antigen-related cell adhesion molecule 1 (CC1) is a cell adhesion molecule within the Ig superfamily. The Tyr-phosphorylated isoform of CC1 (CC1-L) plays an important metabolic role in the regulation of hepatic insulin clearance. In this report, we show that CC1-deficient (Cc1(-/-)) mice are prone to hepatic steatosis, as revealed by significantly elevated hepatic triglyceride and both total and esterified cholesterol levels compared with age-matched wild-type controls. Cc1(-/-) mice were also predisposed to lipid-induced hepatic steatosis and dysfunction as indicated by their greater susceptibility to store lipids and express elevated levels of enzymatic markers of liver damage after chronic feeding of a high-fat diet. Hepatic steatosis in the Cc1(-/-) mice was linked to a significant increase in the expression of key lipogenic (fatty acid synthase, acetyl CoA carboxylase) and cholesterol synthetic (3-hydroxy-3-methylglutaryl-coenzyme A reductase) enzymes under the control of sterol regulatory element binding proteins-1c and -2 transcription factors. Cc1(-/-) mice also exhibited impaired insulin clearance, glucose intolerance, liver insulin resistance, and elevated hepatic expression of the key gluconeogenic transcriptional activators peroxisome proliferator-activated receptor-gamma coactivator-1 and Forkhead box O1. Lack of CC1 also exacerbated both glucose intolerance and hepatic insulin resistance induced by high-fat feeding, but insulin clearance was not further deteriorated in the high-fat-fed Cc1(-/-) mice. In conclusion, our data indicate that CC1 is a key regulator of hepatic lipogenesis and that Cc1(-/-) mice are predisposed to liver steatosis, leading to hepatic insulin resistance and liver damage, particularly when chronically exposed to dietary fat.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19406938     DOI: 10.1210/en.2008-1439

Source DB:  PubMed          Journal:  Endocrinology        ISSN: 0013-7227            Impact factor:   4.736


  31 in total

Review 1.  Hepatic Insulin Clearance: Mechanism and Physiology.

Authors:  Sonia M Najjar; Germán Perdomo
Journal:  Physiology (Bethesda)       Date:  2019-05-01

2.  Carcinoembryonic Antigen Cell Adhesion Molecule 1 long isoform modulates malignancy of poorly differentiated colon cancer cells.

Authors:  Azadeh Arabzadeh; Jeremy Dupaul-Chicoine; Valérie Breton; Sina Haftchenary; Sara Yumeen; Claire Turbide; Maya Saleh; Kevin McGregor; Celia M T Greenwood; Uri David Akavia; Richard S Blumberg; Patrick T Gunning; Nicole Beauchemin
Journal:  Gut       Date:  2015-02-09       Impact factor: 23.059

3.  Ceacam1 deletion causes vascular alterations in large vessels.

Authors:  Sonia M Najjar; Kelly J Ledford; Simon L Abdallah; Alexander Paus; Lucia Russo; Meenakshi K Kaw; Sadeesh K Ramakrishnan; Harrison T Muturi; Christian K Raphael; Sumona Ghosh Lester; Garrett Heinrich; Sandrine V Pierre; Ralf Benndorf; Veronika Kleff; Ayad A Jaffa; Emile Lévy; Guillermo Vazquez; Ira J Goldberg; Nicole Beauchemin; Rosario Scalia; Süleyman Ergün
Journal:  Am J Physiol Endocrinol Metab       Date:  2013-06-25       Impact factor: 4.310

4.  Arctic berry extracts target the gut-liver axis to alleviate metabolic endotoxaemia, insulin resistance and hepatic steatosis in diet-induced obese mice.

Authors:  Fernando F Anhê; Thibault V Varin; Mélanie Le Barz; Geneviève Pilon; Stéphanie Dudonné; Jocelyn Trottier; Philippe St-Pierre; Cory S Harris; Michel Lucas; Mélanie Lemire; Éric Dewailly; Olivier Barbier; Yves Desjardins; Denis Roy; André Marette
Journal:  Diabetologia       Date:  2017-12-21       Impact factor: 10.122

5.  Liver-specific reconstitution of CEACAM1 reverses the metabolic abnormalities caused by its global deletion in male mice.

Authors:  Lucia Russo; Harrison T Muturi; Hilda E Ghadieh; Simona S Ghanem; Thomas A Bowman; Hye Lim Noh; Sezin Dagdeviren; Godwin Y Dogbey; Jason K Kim; Garrett Heinrich; Sonia M Najjar
Journal:  Diabetologia       Date:  2017-09-14       Impact factor: 10.122

6.  Exenatide Prevents Diet-induced Hepatocellular Injury in A CEACAM1-Dependent Mechanism.

Authors:  Hilda E Ghadieh; Harrison T Muturi; Sonia M Najjar
Journal:  J Diabetes Treat       Date:  2017-12-19

7.  Role for hepatic CEACAM1 in regulating fatty acid metabolism along the adipocyte-hepatocyte axis.

Authors:  Lucia Russo; Hilda E Ghadieh; Simona S Ghanem; Qusai Y Al-Share; Zachary N Smiley; Cara Gatto-Weis; Emily L Esakov; Marcia F McInerney; Garrett Heinrich; Xin Tong; Lei Yin; Sonia M Najjar
Journal:  J Lipid Res       Date:  2016-10-24       Impact factor: 5.922

8.  Increased metabolic rate and insulin sensitivity in male mice lacking the carcino-embryonic antigen-related cell adhesion molecule 2.

Authors:  P R Patel; S K Ramakrishnan; M K Kaw; C K Raphael; S Ghosh; J S Marino; G Heinrich; S J Lee; R E Bourey; J W Hill; D Y Jung; D A Morgan; J K Kim; K Rahmouni; S K Rahmouni; S M Najjar
Journal:  Diabetologia       Date:  2011-12-11       Impact factor: 10.122

Review 9.  CEACAM1 loss links inflammation to insulin resistance in obesity and non-alcoholic steatohepatitis (NASH).

Authors:  Sonia M Najjar; Lucia Russo
Journal:  Semin Immunopathol       Date:  2013-11-21       Impact factor: 9.623

10.  Chronic rapamycin treatment causes glucose intolerance and hyperlipidemia by upregulating hepatic gluconeogenesis and impairing lipid deposition in adipose tissue.

Authors:  Vanessa P Houde; Sophie Brûlé; William T Festuccia; Pierre-Gilles Blanchard; Kerstin Bellmann; Yves Deshaies; André Marette
Journal:  Diabetes       Date:  2010-03-18       Impact factor: 9.461

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.